Entasis Therapeutics Holdings Inc (ETTX) Insider Trading
- $133,698,671.16
- $50,188.27
- July 11, 2022
- Innoviva, Inc.
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 11, 2022 | N/A | 7,598,814 | $2.20 | Buy | $16,717,390.80 | |
July 8, 2022 | N/A | 11,671,662 | $2.20 | Buy | $25,677,656.40 | |
Oct. 19, 2021 | General Counsel | 3,759 | $3.19 | Sell | $11,991.21 | |
Oct. 19, 2021 | Insider | 11,974 | $3.19 | Sell | $38,197.06 | |
June 11, 2021 | Major Shareholder | 6,268,975 | $2.00 | Buy | $12,537,950.00 | |
May 3, 2021 | Major Shareholder | 3,731,025 | $2.00 | Buy | $7,462,050.00 | |
Sept. 1, 2020 | Major Shareholder | 4,672,897 | $2.68 | Buy | $12,523,363.96 | |
June 11, 2020 | Major Shareholder | 12,677,490 | $2.50 | Buy | $31,693,725.00 | |
Sept. 28, 2018 | Major Shareholder | 1,089,835 | $15.00 | Buy | $16,347,525.00 | |
Sept. 28, 2018 | Insider | 262,539 | $15.00 | Buy | $3,938,085.00 | |
Sept. 28, 2018 | Director | 453,395 | $15.00 | Buy | $6,800,925.00 |
Insiders are both buying and selling Entasis Therapeutics Holdings Inc stock.
The insider traders at Entasis Therapeutics Holdings Inc are: Innoviva, Inc., Elizabeth M Keiley, Group Holdings (Sbs) Advis Tpg, Holdings A/S Novo, Manoussos Perros, and Nicholas Galakatos
The most active insider trader at Entasis Therapeutics Holdings Inc is Innoviva, Inc. with 6 trades.
Manoussos Perros has sold the most Entasis Therapeutics Holdings Inc stock with a total value of $76,394.12.
Innoviva, Inc. has bought the most Entasis Therapeutics Holdings Inc stock with a total value of $123,329,526.96.
The most recent insider trade for Entasis Therapeutics Holdings Inc was on July 11, 2022.
The single biggest insider buy for Entasis Therapeutics Holdings Inc was from Innoviva, Inc. with a total value of $31,693,725.00 on June 11, 2020.
The single biggest insider sell for Entasis Therapeutics Holdings Inc was from Manoussos Perros with a total value of $38,197.06 on Oct. 19, 2021.